CDC advisers vote to narrow use of J&J vaccine due to concerns about rare blood clots

life-tips
Doses of the Johnson & Johnson COVID-19 vaccine are stacked in boxes at the McKesson facility in Shepherdsville, Ky., on March 1.

The recommendation was prompted by the occurrence of a rare and sometimes fatal blood-clotting problem known as TTS. More than 16 million people in the U.S. have received a shot of the J&J vaccine.

(Image credit: Pool/Getty Images)

Share:

Post a Comment

Designed by OddThemes | Distributed by Blogger Themes